Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lei Yun Shang, founded in 1734 by Lei Da Sheng, is one of China's most prestigious Traditional Chinese Medicine (TCM) institutions, historically operating under the hall name Song Fen Tang. Headquartered in Suzhou, the company is celebrated as one of the "Four Famous TCM Halls" in China and is the custodian of several national intangible cultural heritage formulas. Its flagship product, Liu Shen Wan, is a renowned anti-inflammatory and anti-infective treatment that remains a staple in Chinese households. Today, the Lei Yun Shang Pharmaceutical Group operates as a modern healthcare enterprise integrating R&D, large-scale GMP manufacturing, and an extensive retail pharmacy chain, focusing on respiratory, cardiovascular, and pediatric health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lei Yun Shang Sung Fen Tang.